Cato Research, Your Reliable Partner
Cato Research (CATO) is an international regulatory and clinical contract research organization (CRO) that has been delivering successful outcomes for its clients since 1988. Through highly qualified and experienced personnel located in offices across North America, Europe, Israel, and South Africa, supported by strategic alliances with selected regional CROs, CATO offers tried-and-trusted international coverage.
CATO has the advantage of integrated regulatory, clinical, and scientific expertise. Our highly talented and experienced international team offers services from preclinical through IND (or equivalent), clinical development, and marketing approval to Phase 4 postmarketing research. Our track record includes successes across many different health products, including drugs, biologics, vaccines, cell therapies (including stem cells), nutriceuticals, medical foods, devices, and diagnostics. In terms of diseases and indications, CATO has been involved in a wide variety of projects with a dominant focus in oncology, neurology/CNS, and rare and orphan drug indications. This experience includes leadership of, and involvement in some of the most challenging and innovative products.
What our Sponsors say about us...
“…Your firm consistently supported our company
We have no reservations in considering CATO as an important partner for our future clinical endeavors and recommending CATO to other companies."
- Canadian Medical Technology Co.
“Thank you for your continued support and valuable contribution…
On behalf of our company, we would like to thank you for your continued support and valuable contribution to the success of our regulatory submissions."
- Biotechnology Company Headquartered in Rockville, MD, USA
11480 N. Torrey Pines Road, La Jolla, CA 92037